ABSTRACT A new animal model was developed to determine the effect of obesity upon endogenous triglyceride secretion. Desert sand rats (Psammomys obesus), rodents which become spontaneously obese and hyperinsulinemic when given ad lib. chow, were given intravenous Triton to allow in vivo measurement of triglyceride secretion rates (TGSR). In a group of 18 fasted animals of varying body weight and degrees of obesity, TGSR correlated significantly with body weight (r = 0.68, P < 0.01) indicating that obesity was associated with accelerated endogenous release of triglyceride. In these same animals, basal plasma insulin levels correlated significantly with body weight (r = 0.78, P < 0.001) and TGSR correlated significantly with mean plasma insulin levels (r = 0.73, P <0.001), suggesting that hyperinsulinemia may have been the mechanism through which obesity enhanced TGSR. No correlation was found between basal triglyceride level and either body weight, basal insulin, or TGSR which suggested that individual triglyceride removal rates among the animals may have been variable. To test this hypothesis, seven animals were studied prospectively before and after induction of obesity. There were significant increases (P < 0.02) in all parameters, i.e., weight, plasma insulin level, TGSR, and basal triglyceride level. Thus, when each animal was used as its own control, thereby minimizing the postulated factor of variable individual triglyceride removal, increments in basal triglyceride were shown to accompany the development of obesity, hyperinsulinemia, and accelerated triglyceride secretion.
INTRODUCTION
Body weight appears to be one of a variety of factors influencing circulating triglyceride levels in man. Triglyceride levels are higher following equilibration after experimental weight gain and lower after weight reduction (1) . In addition, obesity is thought to be a contributing factor to the elevated triglyceride levels observed in patients with endogenous hypertriglyceridemia, and consequently, weight reduction has been advised in the treatment of this disease (2) .
The characteristic elevation of both basal and stimulated insulin levels in obese subjects (3) is one conceivable mechanism through which obesity might express its postulated hypertriglyceridemic effect since insulin has been reported to enhance hepatic triglyceride synthesis in vitro (4) (5) (6) . However, correlations between circulating triglyceride and insulin levels in man have been relatively weak (7) . Since an isolated measurement of plasma triglyceride does not distinguish between triglyceride secretion and removal but only represents the balance between the two, a technique which measures triglyceride secretion may more accurately define the possible influence of obesity and its associated hyperinsulinemia upon regulation of circulating triglyceride level.
For several reasons, it is difficult to determine the influence of obesity upon rates of triglyceride secretion in humans. These points include the need to manipulate caloric intake prospectively over an extended period of time to establish desired levels of obesity and hypertriglyceridemia and the lack of universal agreement re- (8, 9) . The sand rats used in this study were trapped in Egypt and transported to Seattle, Wash., where they were maintained in a clean environment which utilized a laminar flow unit. Nutrition consisted of spinach, tap water, salt blocks, and Purina lab chow (56% carbohydrate, 5% fat) (Ralston Purina Co., St. Louis, Mo.) Two basic types of diets were utilized: (a) weight-maintaining (30 g of Purina lab chow daily) and (b) ad lib. (unlimited access to Purina lab chow). All of the rats studied were adult animals. Fasting plasma glucose levels ranged between 62-109 mg/100 ml (Table I) and hematocrits between 3&-56%o. induction and intraperitoneal pentobarbital were used to establish general anesthesia. Temperature was maintained at 370C through the use of heat lamps and rectal probe monitoring. Hind foot veins were used for injections and blood samples were collected from the retro-orbital capillary bed. Plasma volumes were determined through use of 0.2 cm3 of undiluted Evans blue dye; the percent absorbance of a plasma sample collected 5 min after injection of the dye was determined by spectrophotometry.
Triton WR-1339, a nonionic detergent, was injected intravenously and the subsequent increases in triglyceride levels were used to calculate TGSR (10) . The mechanism of action of Triton upon triglyceride metabolism is thought to be through its detergent properties which bind triglyceride, thereby preventing removal of approximately 80-90% of circulating triglyceride (11) . Hence, increments observed in circulating triglyceride after administration of Triton have been interpreted to be a result of triglyceride secretion. A pre-Triton sample was collected immediately before Triton injection; post-Triton samples were collected at 45 and 90 min after the Triton injection (Fig. 1 ). To insure a dose of Triton which would provide a maximal effect, a Triton dose-triglyceride secretion response curve was determined using adult lean nonlipemic animals and doses of 0 (saline control), 30, 60, 90, and 120 mg. TGSR were determined by the equation:
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RESULTS
Triton dose-triglyceride secretion response. Since a statistically significant correlation (r = 0.65, P <0.01) between plasma volume and body weight was found in a group of 21 randomly selected animals who were of varying weight and degrees of obesity (Fig. 2) , plasma volumes used in the equation for calculating triglyceride production rates were estimated on the basis of body weight using the equation of the line given in Fig. 2 plateau in secretion rates in lean animals was observed beginning at approximately the 60 mg dose of Triton (Fig. 3) . For all subsequent determinations of triglyceride production rates, the 120 mg dose of Triton was chosen to insure maximal effect in obese animals; the validity of this choice was demonstrated in a group of obese animals (body weight = 235±14 g; mean ±SD) in whom the 120 mg dose also provided maximal effect (Fig. 4) . TGSR in animals of varying weight and degrees of adiposity. The range of basal (pre-Triton) plasma insulin values for these 18 sand rats was 12-188 uU/ml (Table I ). Assay of the 1: 2, 1: 4, 1: 8, and 1: 16 dilutions of a sand rat plasma sample with an insulin value of 140 /U/ml when undiluted yielded results of 72, 40, 21, and 12, respectively. The mean fasting plasma insulin value for 12 gerbils using the same standard was 17±4-7 /U/ml (mean ±SD).
TGSR correlated significantly with body weight (r = 0.68, n = 18, P < 0.01; Fig. 5 ). In contrast, the preTriton triglyceride level did not correlate significantly with either body weight (r = 0.30) or TGSR (r = 0.15). Statistically significant correlations were found between basal (pre-Triton) plasma insulin level obtained at time 0 min and body weight (r = 0.78, P <0.001; Fig. 6 ) and between TGSR and the mean plasma insulin level (i.e., mean of the insulin values at 0, 45, and 90 min) during the entire procedure (r = 0.73, P < 0.001; Fig.  7 ). The latter correlation was also significant if only the values at 45 and 90 min were used for the mean insulin level (r = 0.67, P < 0.005). The correlations between basal (pre-Triton) triglyceride level and basal insulin level (r = -0.41 ) and mean insulin level during the Triton procedure (r = 0.22) were not significant.
TGSR in animals studied prospectively. All seven animals (Table II) studied prospectively before and after induction of obesity had significant increases in weight (P < 0.02), basal triglyceride level (P < 0.02), triglyceride secretion rate (P <0.02), basal insulin level (P < 0.02), and mean insulin level during the Triton procedure (P < 0.02). No strated significant increases in basal triglyceride level and secretion rates after becoming obese. The fact that the prospective study's control group did not have significant increases in basal triglyceride level or secretion implies that repeated administration of Triton did not, of itself, increase these parameters. The Triton dose-triglyceride secretion response curves for both the lean and obese animals demonstrate that the 120 mg dose caused maximal blockade of triglyceride removal in both groups. Based upon disappearance rates of Triton-incubated "C-labeled serum lipids obtained from Triton-treated donor rats'which were injected in Tritontreated recipient rats, Otway and Robinson (11) estimated that 100 mg of intravenous Triton given to rats comparable in size with ours produced a 90% block in removal. In addition, in the same publication these investigators reported a separate experiment in which preincubation of [ (11) .
Despite the increased TGSR in the obese animals, no significant correlation was demonstrable between preTriton triglyceride concentration and body weight nor with TGSR. However, as shown in the prospective study, weight gain was associated with parallel increases in preTriton triglyceride level and TGSR. These data suggest that simple correlation analysis between triglyceride level and either body weight or TGSR may not be the most sensitive statistical method to detect changes induced in triglyceride transport by obesity, although positive correlations between plasma triglyceride and obesity have been previously reported in man (15) .
As has been previously reported both in sand rats (16) , other types of rats (17) , and in man (1), induction of obesity is associated both with increases in circulating insulin level and in in vitro parameters of insulin resistance (18) . This phenomenon was demonstrated in this study by the significant positive correlation between the basal circulating insulin level and body weight in the group containing 18 lean or obese animals. Moreover, all seven animals in the prospective study had increases in insulin level as they became obese. In general, the insulin levels observed in both the lean and obese sand rats were noticeably higher than those usually seen in man. Dilution studies indicated that the insulin values were not artifactually elevated as a result of incomplete cross reactivity of the immunoreactive material with the insulin antibody, the linear relationship observed between insulin level and sample dilution suggesting that the cross-reactivity between sand rat insulin and albino rat standards was complete. In addition, plasma samples from gerbils contained insulin levels within the range observed for man. Thus, it appears that the sand rat, both in the lean and particularly in the obese state, is characterized by high levels of circulating insulin.
TGSR and circulating insulin level were significantly related. The mean of the three insulin values obtained from the Triton procedure was used for this correlation since it seemed probable that this value more accurately reflected the degree of endogenous insulinization during the time that secretion rates were determined. This relationship remained significant if the 45-and 90 min samples only were used for the mean insulin level. In contrast, the pre-Triton insulin value was used for the correlation between basal insulin and body weight since this insulin value more accurately reflects the basal state.
The fact that pre-Triton triglyceride levels did not correlate significantly with plasma insulin in the group of 18 sand rats studied cross-sectionally is of interest in light of the fact that both of these values increased simultaneously in all the 7 animals studied prospectively. Since insulin level correlated well with rates of triglyceride secretion, and triglyceride level represents a balance between secretion and removal, the fact that triglyceride level did not correlate with insulin level implies that rates of triglyceride removal varied considerably among the animals. If marked variable removal efficiency did occur, correlation analysis between triglyceride level and insulin level might not be a sufficiently sensitive statistical method to detect the effects of increased insulin level upon triglyceride metabolism and may account for the weak correlation between plasma triglyceride and insulin in the 18 cross-sectional studies and in studies previously reported in man (7) . In contrast to the cross-sectional studies, when each animal was used as its own control, the postulated factor of variable removal efficiency among the animals should have been minimized; this may explain why increases in both plasma triglyceride and insulin level appeared to be associated as the animals became obese in the seven prospective studies.
In conclusion, these studies demonstrate that induction of obesity in the sand rat leads to an increase in rates of triglyceride secretion which can be invoked as one possible mechanism to explain the increased levels of plasma triglyceride associated with obesity. The fact that plasma levels of insulin were increased in the obese animals and correlated well with TGSR is consistent with the concept that hyperinsulinemia might have been the mechanism through which obesity expressed its hypertriglyceridemic effect. Although similar hypotheses have been previously formed (19) (20) (21) , this appears to be the first demonstration that in vivo TGSR correlate significantly with circulating insulin levels.
